Tech Company Financing Transactions

Apton Biosystems Funding Round

Apton Biosystems, based in Pleasanton, secured $24 million from Kern Partners, Casdin Capital and Khosla Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
The company intends to use the funds to continue developing its Super-Res sequencing and single-molecule proteomics detection systems.

Company Information

Company Status
Private & Independent
Healthcare IT
Mailing Address
6670 Owens Dr.
Pleasanton, CA 94588
Email Address
Apton Biosystems is a Pleasanton, California-based developer of Super-Res(TM) sequencing and single molecule detection systems for large-scale clinical applications such as early cancer detection and population sequencing. Apton has re-imagined the optical systems for sequencing using super-resolution to evaluate molecules spaced closer than a wave-length of light.
Apton Biosystems LinkedIn Company Profile
Social Media
Apton Biosystems Company Twitter Account
Company News
Apton Biosystems News
Apton Biosystems on Facebook
Apton Biosystems on YouTube

Management Team

Email & Social
Chief Executive Officer
John Hanna
  John Hanna LinkedIn Profile  John Hanna Twitter Account  John Hanna News  John Hanna on Facebook



Browse more venture capital transactions:

Prev: 7/1/2021: Sagetech Avionics venture capital transaction
Next: 7/1/2021: Entera venture capital transaction


Share this article


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary